Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

In transplant-eligible patients who undergo upfront autologous stem cell transplant (ASCT) for multiple myeloma (MM), standard practice is to treat with six to eight cycles of induction therapy followed by high-dose chemotherapy with ASCT. A gap between the end of induction and the day of ASCT exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Bao, Alicia, Zhao, Qiuhong, Kudalkar, Ruchi, Rodriguez, Jose, Sharma, Nidhi, Bumma, Naresh, Devarakonda, Srinivas S., Khan, Abdullah M., Umyarova, Elvira, Rosko, Ashley E., Benson, Don, Cottini, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405820/
https://www.ncbi.nlm.nih.gov/pubmed/37554170
http://dx.doi.org/10.3389/fonc.2023.1216461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405820/
https://www.ncbi.nlm.nih.gov/pubmed/37554170
http://dx.doi.org/10.3389/fonc.2023.1216461

Ejemplares similares